Oruka Therapeutics Inc (ORKA)

SG&A Expense Growth

-6.06%

Quarterly · Period ending:

ORKA logo

ORKA SG&A Expense Growth

Latest reported-6.06%
ORKA Quarterly SG&A Growth (QoQ) (0.00% → -6.06%)
High-resolution chart · PNG

ORKA sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Oruka Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-6.0585%
7.1418%
32.1673%
17.8489%
-15.869%
-14.0198%
59.7271%
33.2624%
68.8623%
9.8684%
-4.1009%
-6.213%
22.7306%
6.9099%
7.3333%
-14.5907%
31.3084%
-37.4635%
36.7706%
0.8058%
2.6468%
-36.5687%
108.7623%
0.1096%
-4%
9.1954%
-0.9112%
-16.0612%
-4.7359%
22.408%
-2.0742%
-8.1244%
-4.7755%
-28.1401%
48.6735%
-6.1303%
-7.4468%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.